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Abstract 
Cranial base and craniocervical junction anatomy can be evaluated from MR and CT 
scans, and lateral skull radiographs. Cranial base anatomy changes during growth, as the 
form of the anatomic structures and their relative positions alter. In disorders of 
compromised bone quality, abnormal changes in the craniocervical junction can lead to 
pathological conditions with possibly life-threatening neurological complications. In this 
investigation these issues have first been addressed by making skull base measurements of 
healthy growing individuals to determine the age-specific normative values used to 
evaluate cranial base structures. These normative values were then employed in the 
following analysis of growing patients suffering from osteogenesis imperfecta (OI), a 
disorder of bone fragility due to abnormal collagen composition. 
 
In healthy individuals’ cranial base measurements, young children demonstrated 
significantly different results from those of older growing individuals and adults. Thus 
studies on patients younger than 9 years should include age-appropriate controls. 
Significant individual variation in skull base measurements during growth may appear, as 
revealed by longitudinal observation. The observed wide ranges, and the fact that the 
position of the odontoid process in relation to skull base structures may individually 
display alternating up- and downward movements, are important to consider when 
conducting follow-up examinations. Nevertheless, a notable deviation from the 
documented normal values is suggestive of pathological development in the craniocervical 
junction. 
 
When comparing the age-specific normal values, skull base abnormalities were found to 
be present in approximately one fifth of OI patients; platybasia was the most frequent 
finding. Patients with haploinsufficiency mutations (which lead to a relatively mild 
phenotype) were less likely to have skull base abnormalities than patients with helical 
glycine substitutions. However, the strongest predictor of skull base abnormality was not 
the type of collagen mutation underlying OI but the clinical severity of the disorder, as 
expressed by the height Z-score. No evidence was found for a protective effect of 
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bisphosphonate treatment, nor for the progression of craniocervical junction pathology 
with age. 
 
Based on this normative data and the observations made in patients with OI, age-
appropriate screening limits for skull base pathology are proposed here, in addition to a 
recommendation for timing of radiological screening in patients with OI. 
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Abbreviations 
Ba Cephalometric landmark basion at the midpoint on the anterior bony margin 
of the foramen magnum of the occipital bone 
BMD  Bone mineral density 
BMP Bone morphogenetic protein 
BMP1 Gene coding for bone morphogenetic protein 1 
C1  First cervical vertebra also known as atlas 
C2  Second cervical vertebra also known as axis 
CRTAP  Cartilage associated protein 
COL1A1 Gene coding for alpha 1 chain of type I collagen 
COL1A2  Gene coding for alpha 2 chain of type I collagen 
CT Computed tomography 
D Cephalometric landmark dens at the cranial tip of the odontoid process 
DXA Dual-Energy X-ray Absorptiometry 
ECM Extracellular matrix 
LEPRE1  Leucine proline-enriched proteoglycan. Gene coding for leprecan or prolyl-
3 hydroxylase enzyme. 
LS aBMD Lumbar spine areal bone mineral density 
M Cephalometirc landmark M-point at the most caudal point of occipital bone 
MRI  Magnetic resonance imaging 
N Cephalometric landmark nasion at the nasofrontal suture 
OI  Osteogenesis imperfecta 
Op Cephalometirc landmark opisthion at the mid-point on the posterior bony 
margin of the foramen magnum 
PNS Cephalometirc landmark posterior nasal spine at the most dorsal point of the 
palatal bone 
PPIB Cyclophilin B. Gene coding for cyclosporine-binding protein. 
S Cephalometirc landmark sella turcica 
SD  Standard deviation 
TGF-β  Transforming growth factor beta 
Wnt Wingless homologue in vertebrates (transcription factor)
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1. Introduction 
Throughout life, bone mass is the net result of the processes of bone resorption and 
formation, which is regulated by genetic and environmental factors. Bone dysplasias, such 
as osteogenesis imperfeca (OI), disrupt the balance of bone remodelling. 
 
OI is a heterogeneous group of connective tissue disorders characterized by bone fractures 
that arise from even low impact trauma. Progressive bone deformities develop frequently 
in severe OI types. OI is a disease of collagen I rich tissues; particularly bone, where 
disorganized matrix and reduced bone mass, result in the characteristic brittleness. The 
disorder is caused by a mutation in one of the two type I collagen genes; COL1A1 or 
COL1A2 in most patients with OI. Small numbers of patients, however, carry a mutation 
in genes involved in collagen protein assembly, leading to abnormal folding of type I 
collagen. (Marini et al. 2010) 
 
A serious potential complication of OI is a deformity of the craniocervical junction. The 
craniocervical junction consists of the occiput, housing the foramen magnum, atlas and its 
axis, as well as ligaments and other associated structures. It forms a vital passage for the 
central nervous system. (Menezes 2008a) Craniocervical junction anomalies also affect a 
wider patient population; they are possible complications of several syndromes, such as 
Down or achondroplasia, or can arise from congenital malformations (Luyendijk et al. 
1978, Menezes 2008e). The pathology of the craniocervical junction can be asymptomatic, 
or result in even life threatening symptoms caused by compression of the medulla, 
cerebellum, cervical nerve roots, lower cranial nerves or the vascular supply to these 
(Sawin and Menezes 1997, Smoker and Khanna 2008, Bishop 2010, Forlino et al. 2011). 
 
Data on the normal dimensions of the craniocervical junction and the associated growth-
related changes in healthy children has been scarce, despite being a prerequisite for the 
accurate diagnosis and better understanding of the development of basilar anomalies. 
Similarly, the natural course of craniocervical junction anomalies, in growing patients 
with OI, has for the most part been unexplored despite the importance of early 
intervention before serious symptoms arise. 
Review	  of	  the	  literature	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2. Review of the literature 
2.1. Bone metabolism and growth 
The skeletal system, composed of cartilage and bone, aids locomotion, and supports body 
weight. The skeleton also protects the internal and sensory organs, the central nervous 
system, and the respiratory tract, whilst acting as storage for calcium and phosphate. The 
facial skeleton is embryologically derived from the cranial neural crest, whereas the rest of 
the skeleton, including cartilage, is derived from mesoderm (Leucht et al. 2008). Mature 
bone is actually specialised connective tissue composed of bone cells, proteins, and 
minerals. Histologically, mature bone can be divided into two types: 1. Cortical or 
compact bone that has a dense ordered structure and is mainly found in the diaphyses of 
long bones and the outer surfaces of flat bones. 2. Cancellous or trabecular bone, that is 
lighter, less compact, and has an irregular structure. Trabecular bone is less abundant and 
forms the metaphysis and epiphysis of long bones and the inner parts of flat bones. 
Trabecular bone is ideally suited to withstand compressive stress and hence is the 
predominant bone type in the vertebrae. (Datta et al. 2008) 
 
Mature bone tissue hosts three types of cells: osteoblasts, osteocytes, and osteoclasts. 
Stromal marrow cell derived osteoblasts function in bone formation by synthesizing and 
secreting collagenous and non-collagenous matrix proteins (Shi et al. 1996). 
Approximately 10-15% of osteoblasts are transformed into osteocytes. Multifunctional 
osteocytes are the most abundant cell type in bone. They are believed to transmit signals 
for bone remodelling via dendritic processes and by apoptosis in response to mechanical 
strain. Hematopoietic stem cell derived osteoclasts are involved in the resorption of bone 
tissue by secreting matrix metalloproteinases and cathepsins. (Aarden et al. 1994) 
Osteoblasts are located on the surfaces of bone tissue, while osteoclasts are found both 
within the calcified matrix and on calcified bone surfaces. (Datta et al. 2008) 
 
The extracellular matrix (ECM) consists of organic components (collagen fibers 
embedded in ground substance) and inorganic components (mainly calcium and phosphate 
Review	  of	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in the form of hydroxyapatite). These minerals contribute approximately 60% of the 
weight of the bone. About 90% of the matrix proteins are collagen, making it the most 
abundant group of proteins in the body. Collagen gives structural support to bone, and is 
an essential component of cartilage, skin, ligaments, and cornea. (Viguet-Carrin et al. 
2006, Datta et al. 2008) Types I through V are the most abundant collagen types in the 
body. Type I collagen is the predominant constituent of bone, and type II the main 
component of cartilage. The tensile properties of collagen fibrils serve to increase the 
elasticity of these tissues. The banded collagen fibrils in connective tissues mostly consist 
of more than one type of collagen molecule similar in structure. (Burgeson 1988, reviewed 
by Lodish et al. 2000) Changes in the composition of the organic matrix affect bone 
mineralization and thus the mechanical properties of bone. (Bala et al. 2011) 
 
Type I collagen accounts for approximately 90-95% of the collagen content of bone 
(Huber 2007), whilst approximately 5% comprises type V collagen, and the remainder is 
bone-specific phospho- and glycoproteins (Niyibizi and Eyre 1989). Type I collagen is 
mainly produced by fibroblasts and osteoblasts, and is composed of two alpha-1 chains 
and one alpha-2 chain encoded by COL1A1 and COL1A2 genes, respectively (Figure 1). 
These three polypeptide chains begin to fold into a triple-helical rod at the carboxyl-
terminal (C-terminal) end, with the folding proceeding towards the amino-terminal (N-
terminal) end. (Engel and Prockop 1991) Posttranslational modification in the 
endoplasmic reticulum includes hydroxylation of prolyl and lysyl amino acids. (Marini et 
al. 2010) Intracellular stages are required to process and assemble the procollagen 
molecule, and extracellular stages to convert it into collagen and incorporate the mature 
collagen molecules into stable, cross-linked fibrils. The resulting mature collagen fibrils 
form by lateral interactions of the triple helices. (reviewed by Lodish et al. 2000) 
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Figure 1 Schematic illustration of a collagen trimer. Procollagen is composed of a twisted 
center and loose ends (C-terminal and N-terminal). Hydroxyproline aids crosslinking 
between the α chains and is therefore essential for stability of the collagen molecule. 
In order for the strength of the bone to be maintained, the process of bone turnover must 
be carefully regulated. Bone metabolism relies on complex Wnt/β-catenin and TGF-
β/BMP mediated signaling pathways to achieve proper rates of growth and differentiation. 
These pathways modulate the key transcription factor Runx2 that is essential for 
osteoblast differentiation and embryonic bone formation. Signaling pathways include the 
action of several hormones, including parathyroid hormone, vitamin D, growth hormone, 
steroids, calcitonin, and insulin-like growth factor, as well as several other cytokines. 
(Canalis et al. 1988, Datta et al. 2008) 
 
Bone undergoes constant remodeling as a response to functional demands transmitted via 
muscle attachments to reshape or replace bone during growth and following injury. Bone 
is a self-renewing tissue (Seeman and Delmas 2006). This inherent regenerative capacity 
is attributed to skeletal progenitor cells, located for example in the periosteum. 
Proliferating progenitor cells can differentiate into either chondrocytes or osteoblasts, 
which deposit new mineralized matrix. Matrix is continuously resorbed by osteoclasts, 
which in turn stimulates new osteoblastogenesis. (Leucht et al. 2008) During childhood, 
bone turnover is high and bone formation slightly exceeds resorption. In a healthy adult, 
the bone turnover rate is about 10% of the skeleton per year (Leucht et al. 2008). Peak 
bone mass is reached in the twenties, after which bone formation rate decelerates. The 
combined effect of rate of bone turnover, quality of the collagen-rich ECM, size, structure, 
geometry, and mineral density determines the overall mechanical properties of the skeletal 
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system (Seeman and Delmas 2006). These determinants are affected by diaseases such as 
osteoporosis, Paget’s disease, osteopetrosis, and osteogenesis imperfecta. 
2.2.  Neurocranium and craniocervical junction  
2.2.1. Anatomy 
The cranial base, which is formed by the ethmoid, sphenoid, occipital, paired frontal, and 
paired parietal bones, can be divided into anterior, middle, and posterior cranial fossae. 
The cranial base houses a complex of foramina that form vital passages for neurovascular 
structures. The largest of these is foramen magnum in the occipital bone. The 
craniocervical junction is defined as the region comprising the occiput, atlas and its axis, 
as well as ligaments and other associated structures. The sagittal diameter of the foramen 
magnum is normally 35±4mm, and the transverse diameter is slightly less. (Menezes 
2008a). Sagittal diameter less than 25mm has been suggested to be pathological (Hinck et 
al. 1961). 
 
The joint connecting the neurocranium and spine is comprised of the first cervical 
vertebra, atlas (C1), and its axis (C2). They are specialized to allow a wide range of head 
movement in flexion, extension, lateral bending, and lateral rotation. The ring-like atlas 
consists of an anterior and a posterior arch and two lateral masses encircling the vertebral 
foramen. The axis, in contrast, incorporates a large corticocancellous bony protuberance 
called the odontoid process or dens, which has a narrowed waist and thickened cortical tip. 
The joint surfaces of the skull base, atlas, and second cervical vertebra have little inherent 
stability. Thus, the stability of this region is mainly determined by ligamentous structures. 
(reviewed by VonTorklus and Gehle 1972, Menezes 1998) 
 
The alar ligaments connect the medial surface of the occipital condyles to the lateral tip of 
the odontoid process. The apical ligament connects the caudal end of clivus to the superior 
tip of the odontoid (Figure 2). Tectorial membrane is a continuation of the posterior 
longitudinal ligament and is composed of a deep and a superficial layer. Between the 
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apical ligament and the deep layer of the tectorial membrane is the cruciate ligament 
bridging the clivus and the axis body, and a narrow transverse ligament, which extends 
between the upper ends of the lateral masses of the atlas. The transverse atlantal ligament 
and accessory atlantoaxial ligament are additional supportive structures. Posteriorly, the 
upper cervical spine has less ligamentous support; only the atlantoaxial and atlanto-
occipital membranes. (Tassanawipas et al. 2005, Tubbs et al. 2011) 
 
Figure 2 Schematic illustration of the main ligaments of craniocervical junction connecting the 
clivus on the occipital bone to C1 and C2. Modified from Netter, Frank. Atlas of 
Human Anatomy 1989 Novartis, USA. 
2.2.2. Prenatal development  
During human embryogenesis, 42 somites are formed by the end of the fourth week of 
gestation. Each somite differentiates into dermatome, sclerotome, and myotome. Of these, 
the sclerotomes go on to form the vertebral bodies, each of which receives contributions 
from two adjacent somites; whereas neural arch is derived from a single somite. The 
fourth occipital sclerotome, termed proatlas, divides to ultimately form the anterior 
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tubercle of the clivus, the anterior margin of foramen magnum, the occipital condyle, the 
lateral atlantal masses, the superior portion of the posterior arch of atlas, the apical tip of 
odontoid process, as well as the apical, cruciate, and alar ligaments. The most inferior part 
of the axis arises from the second cervical sclerotome (Figure 3). (Matsuoka et al. 2005, 
Menezes 2005, Pang and Thompson 2011) 
 
Skull bones have two separate origins. Those of the face arise from the neural crest and 
are thus of ectomesenchymal origin, whereas those of the cranial vault and base arise from 
the paraxial mesoderm of the somitomeres and the first five somites (Cobourne 2000). 
Several studies and transgenic-mouse models demonstrate the role of gene families that 
act as regulators of gene transcription in determining the embryonic plan of the developing 
craniofacial complex. The Pax family of regulatory genes is involved in somatic 
differentiation and sclerotomal resegmentation (Pang and Thompson 2011). Combinatorial 
expression of the homeobox-containing Hox genes has also been shown to be important in 
patterning and positional identity of distinct regions of the cranium and cervical vertebrae 
(Cobourne 2000). 
 
Sella turcica, the midpoint of which has been used as a reference point in our study, refers 
to the bony nest of the pituitary gland. The pituitary gland begins its development in the 
third gestational week and is a compound structure. The posterior lobe forms from a 
diverticulum of the diencephalic floor called the infundibulum, whereas the anterior lobe 
forms from an evagination of the ectodermal roof of the stomodeum called Rathke’s 
pouch (Schoenwolf et al. 2009). 
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Figure 3 Schematic illustration of the embryology of the craniocervical junction. The 
basiocciput, tip of the odontoid, and ligaments attached to it, develop from the fourth 
occipital sclerotome. The odontoid process is formed from the caudal part of the 
fourth occipital and the cranial part of the first cervical sclerotomes.  The most 
inferior portion of the axis body is derived from the caudal part of the first cervical 
and the cranial part of the second spinal sclerotomes. 
Embryonic cartilage formation begins by the seventh week of gestation. The cranial base, 
that comprises a major part of the fetal chondrocranium, develops from three pairs of 
cartilaginous precursors: the prechordal, hypophyseal, and parachordal cartilages. These 
cartilages also contribute to protection of the brain and sensory organs together with 
cartilaginous capsules that develop around the otic and nasal pits. The caudalmost paired 
parachordal cartilages are derived from the occipital sclerotomes and the first cervical 
sclerotome. Thus they are modified vertebral elements. The parachordal cartilages form 
the base of the occipital bone. The hypophyseal cartilages fuse to form the body of the 
sphenoid bone. The prechordal cartilage gives rise to the ethmoid bone, which together 
with the nasal and turbinate bones encapsulates the nasal cavity. (Bosma 1975, 
Schoenwolf et al. 2009)  
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Bone formation takes place by two major mechanisms: endochondral and 
intramembranous ossification. During endochondral ossification mesodermally-derived 
osteochondral progenitors differentiate into chondrocytes to form a cartilage framework 
for the future bone (reviewed by Gilbert 2010). Ossification of the endochondrally formed 
cranial base begins during the second and third fetal months. Autonomously developing 
cranial base forms a platform for the growth of the rest of the cranium. Within the cranial 
base, synchondroses remain cartilaginous joints between the different ossification areas. 
Synchondroses are important growth centers that resemble histologically epiphyseal 
growth plates of long bones, but are bipolar in structure. (Björk 1955, reviewed by Bosma 
1975) Long bones and vertebrae also develop via endochondral ossification (Mackie et al. 
2011). 
 
Facial bones and most of the cranial vault develop from neural crest-derived 
ectomesenchymal tissue through intramembranous ossification. During this process, 
osteochondral progenitors differentiate directly into osteoblasts to form membranous bone 
(reviewed by Gilbert 2010). Intramembranously formed flat bones grow to meet each 
other, and are then joined by sutures where appositional growth continues. Sutures are 
sites of growth (reviewed by Bosma 1975). Sutural growth in the cranial vault 
accompanies the enlargement of the brain, and similarly, growth of the respiratory tract, 
eye bulb, neck, and facial musculature are thought to contribute to the amount of growth 
in the number of sutures between facial bones. In addition to growth in sutures and 
synchondroses, the neurocranium also grows by surface apposition and resorption in 
response to forces from the enlarging brain. This occurs similarly in the face; the nasal 
cavity, for instance, vertically enlarges through lowering of the palate by resorption on the 
nasal surface along with apposition on the oral surface. Patency of the calvarial sutures 
provides malleability of the head during delivery. (Björk 1955, Shapiro and Robinson 
1976, Moss 1997, Rice et al. 2003) 
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2.2.3. Postnatal development 
The neurocranium is incomplete at birth. Similarly, the craniocervical junction of children 
is immature and differs from that of adults, both biomechanically and physiologically. 
Growth takes place sequentially, where the anterior fossa completes its growth first, 
followed by the posterior and middle fossae. Growth of the cranial base and face follow 
closely that of the calvaria. The calvaria, the cranial base, and the facial complex display 
an interrelationship, where forces from one complex influence the others. (Goodrich 2005) 
 
Postnatal growth is regulated by genetic, epigenetic, and environmental factors (Bosma 
1975, Enlow and Azuma 1975, Moss 1997). Environmental regulation is well displayed, 
for example in individuals with upper airway obstruction leading to altered craniocervical 
posture, which in turn affects the morphology of the first cervical vertebra. Growth 
changes include a smaller than average vertical dimension of the atlas dorsal arch. 
(Kylämarkkula and Huggare 1985, Solow 1992) Pathological conditions, such as 
craniosynostosis and hydrocephalus, leading to increased intracranial pressure, may in turn 
secondarily affect the cranial base morphology (reviewed by Bosma 1975, Perlyn et al. 
2001, Goodrich 2005). The severity of the dysmorphology depends on the timing of the 
development of the pathology. Growing patients with untreated hydrocephalus exhibit a 
more obtuse anterior cranial base angle than healthy or treated children (Huggare et al. 
1989). 
 
The cranial base anterior to sella stabilises by 7 years of age through ossification of the 
spheno-ethmoidal and inter-sphenoidal synchondroses (Figure 4) (Björk 1955). Among 
cranial base synchondroses, the spheno-occipital synchondrosis is the most important site 
for sagittal and vertical growth. The spheno-occipital synchondrosis ossifies by 17 years 
of age until which time the clivus grows in length (Shirley and Jantz 2011). 
Simultaneously occipital bone drifts downwards and backwards as the brain is displaced 
by its growth resulting in a virtually parallel lowering of the foramen magnum in relation 
to the anterior cranial fossa. (Björk 1955) 
 
During normal development, the anterior cranial base angle is obtuse at birth and 
decreases during the first five years, after which it remains fairly stable (Kerr and Hirst 
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1987). Most of the observed decrease in the anterior cranial base angle has been suggested 
to occur during the first two years after birth (George 2005). 
 
 
Figure 4 Synchondroses of the anterior cranial base. 1.Spheno-ethmoidale 2.Inter-sphenoidale 
3.Spheno-occipitale. The anterior cranial base angle is displayed with dashed lines. 
In early infancy the development of atlas proceeds from pre- and postnatally formed 
ossification centres that expand towards each other to form ventrally neurocentral 
synchondroses. Atlas should be a complete ring by 3 years of age as a result of fusion of 
the lateral atlantal masses. (Wang et al. 2001, Menezes 2008b) 
 
At birth, the odontoid process is still separated from the body of the axis by a 
cartilagenous band, termed dentocentral synchondrosis (Figure 5). This synchondrosis lies 
below the superior level of the vertebral body (corpus of the axis C2) and is not visible on 
radiographs. The dentocentral synchondrosis gradually closes between 3 and 8 years of 
age. It contributes to the overall longitudinal growth of the odontoid process and vertebral 
body. Growth in height of the odontoid process also occurs inferiorly at the end plate 
physis and at the tip of the odontoid. (reviewed by VonTorklus and Gehle 1972, Menezes 
1998, Piatt and Grissom 2011) The odontoid process is mineralized enough to be observed 
on lateral skull radiographs at birth, whereas the tip, called ossiculum terminale, is visible 
only after around 3 years of age when its ossification has proceeded. The tip of the dens 
fuses with the remainder of the odontoid process by 12 years of age. (Ogden 1984, 
1
2
3
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reviewed by Lovell et al. 2006) In healthy children, observed from the age of three months 
until 15 years, the growth rate of odontoid height has been found to be fastest during the 
first five years after birth, and become linear thereafter (Wang et al. 2001). The height of 
the odontoid process has been proposed to range from 14.4 mm to 21.3 mm in adults. In 
adult females, the height is on average 4.5 mm less than in adult males. (Schaffler et al. 
1992, Çokluk C et al. 2006) 
 
Figure 5 Development of the cervical vertebrae. The paired neurocentral synchondroses (A) 
unite the neural arch to the anterior arch (body) of the atlas. Neural arches fuse 
posteriorly by 3 years of age, and neurocentral synchondroses by 8 years of age, at 
which time the vertebral canal has reached its adult size (Piatt and Grissom 2011). 
The odontoid process develops from two primary ossification centers that fuse by 3 
months of age; the C2 corpus appears by the fifth fetal month and is separated from 
the dens by the dentocentral synchondrosis (B). Centrum has superior and inferior 
epiphyses and subsequent ossification centres. The dentocentral synchondrosis fuses 
at 3–8 years. The ossiculum terminale (C) at the tip of the dens appears after 3 years 
of age and coalesces with the odontoid process by 12 years of age. The inferior 
epiphyseal ring appears at puberty and fuses at about 25 years of age. 
Growth after birth involves rate variations at different ages in addition to changes in body 
proportion. The head makes up 25% of the standing height in infancy but only 13% at 
skeletal maturity. The height of the vertebral column will nearly triple from birth to 
adulthood. The measurement of sitting height provides an indirect reflection of spinal 
growth. During the first 5 years of life, sitting height and subischial length (i.e. the growth 
of the lower limbs) display similar growth velocity. From the age of 5 years to puberty, 
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sitting height accounts for one third of the gain, whereas subischial length accounts for 
two thirds. From puberty to maturity, the ratio is reversed. In an adult, the vertebral 
column makes up 60% of the sitting height, whereas the head represents 20% and the 
pelvis 20%. Strong correlation exists between armspan and standing height. (Dimeglio 
2001) 
 
Post-adolescent growth in the vertebral column progresses slowly, similar to most areas in 
the head and face. Vertebral bodies continue to grow between the ages of 20 and 30 years 
by apposition of bone to both ends. During this time, the total vertebral body height 
increases by 3-5 mm on average. After the age of 50 years, the vertebral height starts to 
decline. (reviewed by Harrison et al. 1977) On the other hand, intervertebral discs have 
been found to increase in height until 10 years of age and remain constant thereafter. 
(Stokes and Windisch L 2006). 
2.3. Osteogenesis imperfecta 
Osteogenesis imperfecta (OI), also known as brittle bone disease, is a heterogeneous group 
of inherited connective tissue disorders. The term OI was established in 1895 (Buday 
1895), prior to which various names of the condition were used. Some of the most 
common alternatives were Ekman-Lobstein syndrome, Vrolik syndrome, and the “glass-
bone disease”. The earliest known studies on OI date back to 1788, performed by the 
Swede Olof Jakob Ekman. He described the condition in his doctoral thesis delineating a 
family in which persons in three generations had a condition that he termed "osteomalacia 
congenita". (King and Bobechko 1971) 
2.3.1. Molecular basis 
The etiology and genetic basis of OI remains partly unknown today. OI is caused by 
abnormal formation of type I collagen; either as a quantitative or a structural defect. 
Deposition of new osteoid by single osteoblasts is reduced in OI. Subsequent increase in 
cell number is not sufficient to compensate for the deficiency, resulting in low bone mass 
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(Rauch et al. 2000). In addition to defects in collagen production, mutations causing OI 
also affect the overall composition and organization of bone matrix (Forlino et al. 2011). 
Altered noncollagenous protein content in matrix is believed to disrupt the mineralization 
dynamics leading to matrix hypermineralization. Hypermineralized bone is a common 
feature of quantitative and qualitative collagen defects, as well as of CRTAP defects in 
humans and mice. Thus, in addition to passive deposition of minerals, an active process is 
believed to take place, where matrix abnormality leads to a differentiation defect of 
osteoblasts or osteocytes that alters expression of noncollagenous proteins involved in the 
control of mineralization. (Cabral et al. 2011, Forlino et al. 2011) 
 
The phenotypic severity of OI depends on which amino acid chain in a collagen molecule 
is affected. A defect in α1(I) chain tends to result in a more severe clinical outcome than 
α2(I) defects, resulting in two helix compositions. Complete absence of the α1(I) chain 
leads to a lethal phenotype (Forlino et al. 2011). Missense mutation of glycine in the 
triple-helical region of type I collagen generally leads to OI. Phenotypic severity is 
affected by the position of the glycine substitution in the helix and which amino acid the 
glycine is substituted to. (Roughley et al. 2003, Forlino et al. 2011) The general tendency 
is towards a more severe clinical outcome when the glycine substitution occurs in the 
α1(I) chain towards the carboxyl-terminal end of the molecule, as compared to milder 
phenotypes occurring by a similar mutation towards the amino-terminal end (phenotype 
gradient model) (Roughley et al. 2003). Bodian et al. (2008) have presented a more 
detailed model for lethality prediction. Approximately 80% of glycine substitutions in 
α2(l) and the majority of splice sites are non-lethal. To date, more than 1000 independent 
mutations causing OI are recognized, of which a majority are a glycine substitution in the 
triple helical region (Dalgleish 1997 and 1998; 
www.le.ac.uk/genetics/collagen/index.html, visited on March XV, 2012). 
 
The majority of patients with OI have an autosomal dominant form caused by primary 
defects in type I collagen, which in addition to affecting ECM structure and 
mineralization, cause intracellular stress, disrupt interactions between collagen and non-
collagenous proteins, and cause abnormal cell-cell and cell-matrix interactions. (Forlino et 
al. 2011) Type I OI is caused by frameshift or point mutations in most cases, or rarely by a 
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splice site mutation, creating a premature termination codon in COL1A1 transcript. This 
produces unstable transcription products that are destroyed by nonsense-mediated decay, 
leading to reduced formation of α1 chain and haploinsufficiency of type I collagen 
(Willing et al. 1996, Bishop 2010). In types II to IV OI, 80% of cases are due to a glycine 
substitution and 20% are due to a splice site in either COL1A1 or COL1A2 genes (located 
on chromosome 17 and 7 respectively) leading to structural alteration of type I 
procollagen (Table 1). Substituting residues may disrupt non-covalent bonds causing local 
unwinding of the triple helix and excess post-translational modification of the collagen 
helical region. Mixture of normal and mutant α-chains results in matrix heterogeneity and 
contributes to phenotypic severity. (Roughley et al. 2003, Forlino et al. 2011) 
 
Autosomal recessive forms collectively account for approximately 5% of the OI cases 
detected in Europe and North America (Venturi et al. 2012). They are usually caused by a 
null mutation leading to deficiency of proteins involved in collagen posttranslational 
modification, folding, or secretion. A mutation affecting the enzyme complex responsible 
for posttranslational hydroxylation of the position 3-proline residue of COL1A1 is often 
present. Such genes are CRTAP (cartilage-associated protein), LEPRE1 [leucine proline-
enriched proteoglycan, also called leprecan or prolyl-3-hydroxylase-1 (P3H1)], and PPIB 
(cyclophilin B). (Marini et al. 2010, Forlino et al. 2011) Gene products of these three form 
a complex that modifies proline into hydroxyproline, a process that appears to be critical 
for the normal folding and assembly of collagen (Barnes et al. 2006, Baldridge et al. 
2008). Recessive OI can also be caused by a defect in collagen chaperone genes such as 
SERPINH1, FKBP10, and OSX/SP7, that are essential for correct helical structure. (Van 
Dijk et al. 2009, Christiansen et al. 2010, Lapunzina et al. 2010, Kelley et al. 2011) 
Mutation in SERPINF1, encoding pigment epithelium-derived factor, leads to a 
mineralization defect with a distinctive histology (Homan et al. 2011). Mutation in BMP1 
has also been linked with autosomal recessive OI (Asharani et al. 2012, Martínez-Glez et 
al. 2012). 
 
Patients with dominant types of OI, and recessive types VII and VIII, have high bone 
turnover with elevated osteoblast and osteoclast activity. Their observed bone tissue 
abnormalities include lower bone mass than in age-matched controls, lower cortical bone 
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thickness, and osteopenia (Jepsen et al. 1997, Kocher and Shapiro 1998, Boyde et al. 
1999, Edouard et al. 2011, Forlino et al. 2011). In children, OI can cause clinical 
osteoporosis that differs from idiopathic juvenile osteoporosis by its hereditary nature. No 
deficiency in serum calcium and vitamin D metabolite levels is present in OI as in 
osteomalacia. (Kocher and Shapiro 1998, Gloriex 2008, Edouard et al. 2011) The 
observed fragility of bones in OI, is caused by high stiffness combined with low bone 
mass. 
2.3.2. Clinical features 
A population incidence of 1:5000-1:10 000 inhabitants has been reported worldwide for 
OI (Stoll et al. 1989, Andersen and Hauge 1989, Byers et al. 1991, Glorieux 2008). 
Reports on rare recessive mutations are often of specific populations or isolated families, 
which thus display a high local disease frequency (Barnes et al. 2006, Baldridge et al. 
2008). Official calculations on the number of OI patients have not been conducted in 
Finland. The Finnish Skeletal Dysplasia Registry at Helsinki University Central Hospital, 
maintained on a research basis, includes more than 300 known OI cases. The Finnish 
disease heritage includes a variety of rare hereditary diseases that are overrepresented in 
Finland (Norio 2003). Greater incidence than average of recessive OI types has not been 
documented in Finland, however. 
 
Even though genetic testing has become more common in recent years, diagnosis of OI is 
still most often based on typical clinical and radiological findings. Medical and family 
histories are cornerstones in arriving at the correct diagnosis. Distinguishing OI from non-
accidental injury, such as child abuse, can be complex in some cases. (Paterson et al. 
1993) 
 
A Dual-Energy X-ray Absorptiometry (DXA) assessment of bone mineral density (BMD) 
may help to establish diagnosis of OI, which usually associates with low BMD. Typical 
radiological findings include vertebral fractures, long bone fractures and bowing, 
generalized decrease in density and thinning of bones, coarsening of the trabecular pattern, 
excessive intersutural Wormian bones, and certain characteristic features associated with 
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the recessive OI types. (Cremin et al. 1982, Hayes et al. 1999, Glass et al. 2004) 
Diagnostic methods can also include molecular analysis of type I collagen on cultured 
fibroblasts from a skin biopsy, or genomic sequence studies on DNA obtained from blood 
or saliva specimens, for example. 
2.3.2.1. General symptoms 
OI is associated with bone fragility, bone pain, short stature, and joint hypermobility 
(Glorieux 2008, Basel and Steiner 2009). Joint hypermobility in OI is believed to be 
related to the collagen defect. This view is supported by the overlap in symptoms between 
OI and other connective tissue disorders, such as Marfan and Ehlers-Danlos syndrome 
(Grahame 1999). Lax joints tend to be less stable, to sublux or dislocate, and are generally 
more susceptible to trauma. 
 
Truncal height is reduced more in the severe forms of the disorder than in the mild forms, 
and the same pattern applies for the ratio between armspan and height; an increase is seen 
in children with severe disorder types (Lund et al. 1999). The cause of the short stature 
seen in OI is unclear. Collagen type II predominates in the growth plate cartilage of long 
bones, and thus linear growth could be expected to be normal in patients with OI. 
Nevertheless, morphological changes in the growth plate have been observed in OI 
(Sanguinetti et al. 1990). Compression fractures contribute to the reduced vertebral height, 
but the main cause of short stature is likely to be associated with the function of 
osteoblasts. Unresponsiveness of osteoblasts to normal growth factors or defective 
osteoblast/bone matrix feedback on the growth hormone and somatomedin axis have been 
suggested in the dominant OI types (Marini et al. 1993). The greater impact on growth of 
qualitative collagen defect than of quantitative defect could reflect their different 
consequences on the osteoblast differentiation (Shi et al. 1996, Lund et al. 1999). In the 
severe forms of OI height is already reduced at birth. Platyspondyly is a common finding 
in older patients, corresponding to the reduction of truncal height. Whether platyspondyly 
is caused by biomechanical (reduced bone mineral content), or by biosynthetic 
abnormalities (reduced growth potential of the spine), is yet to be determined. (Lund et al. 
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1999) The recessive types, with extreme short stature, are caused by deficiency of proteins 
that notably function in both cartilage and bone (Marini et al. 2010). 
 
In severe forms of OI progressive deformity, barrel shaped chest, and scoliosis are 
commonly found. Patients are often in a hypermetabolic state with increased respiratory 
and heart rates. Recurrent pneumonia, right-sided heart failure, valvular insufficiency, and 
aortic root dilatation also are typical. Cardiovascular and respiratory system 
manifestations are considered secondary to skeletal changes, such as scoliosis and rib 
fractures. (Hortop et al. 1986, Singer et al. 2001, Forlino et al. 2011) Vertebral 
deformities are generally common in OI, with prevalence ranging from 39% to 100%. 
(Falvo et al. 1974, Norimatsu et al. 1982, Ishikawa et al. 1996) 
 
Blue sclerae is a typical characteristic of certain OI types. Patients often display 
progressive hearing loss that usually begins in the early twenties or thirties and is twice as 
common in women as in men. Conductive hearing loss is caused by otosclerosis-like 
damage to the ossicles in the middle ear. Its prevalence in the Finnish adult OI population 
is 58%. No correlation has been found between hearing loss and collagen mutation type or 
mutated collagen gene (types I, III and IV OI examined) (Kuurila et al. 2000, Kuurila et 
al. 2002). 
 
Typical clinical characteristics also include certain dental and occlusal features. A total of 
10-50% of OI patients display dentin dysplasia that clinically, histologically, and 
radiologically resembles dentinogenesis imperfecta (Lukinmaa et al. 1987, Waltimo and 
Lukinmaa 1997). The presence of dentin dysplasia, as well as normal color of sclera, 
implies qualitative collagen defect. OI patients may exhibit hypodontia, delayed tooth 
eruption, impaction of teeth, and a high incidence of malocclusion. (Lukinmaa et al. 1987, 
O'Connell and Marini 1999, Malmgren and Norgren 2002, Waltimo-Sirén 2011). 
2.3.2.2. Classification 
At the beginning of the 20th century, OI was divided into two forms; congenita and tarda. 
The latter was considered a milder form, in which fractures occurred only after birth. In 
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the following years, the vast clinical variation of symptoms and the inherited nature of the 
disorder was recognised. As a result, Sillence and co-workers (1979a) presented a more 
comprehensive classification. The original Sillence classification that gained general 
acceptance is based on clinical and radiological characteristics and divides the disorder 
into types I through IV (Sillence et al. 1979a and 1979b). Sillence classification was later 
extended to include histologically, radiologically, and genetically distinct OI types (Table 
1) (Roughley et al. 2003, Rauch and Glorieux 2004). The classification of OI is a subject 
of ongoing debate among researchers. 
 
OI continues to be an essentially clinical diagnosis; clinical severity is the central 
parameter of the classification (Van Dijk et al. 2010). Classification of an individual 
patient is not always straightforward, however, because the clinical symptoms present a 
continuum. Therefore, a genotype-based classification has also been proposed (Forlino et 
al. 2011). Mutation-based classification appears more individual and might lead to an 
assumption of individual mutation-targeted treatment, whereas phenotype-based 
classification corresponds more closely with the current phenotype-guided treatment 
protocols. In general, the phenotype-genotype correlation in OI is somewhat limited 
(Rauch et al. 2010, Van Dijk et al. 2010). 
 
Type I is the most common form of OI. It is clinically the mildest type with normal or 
nearly normal height, increased risk of fracture, but usually no deformity. Blue sclerae is a 
common finding. Type II OI is considered lethal perinatally due to respiratory problems. 
Type III OI is characterized by progressive bone deformity and short height. Fracture 
incidence without medication remains high throughout life. Dentine dysplasia is a frequent 
finding. Type IV OI is clinically the most diverse type. Total body height is often 
decreased from mean values for age. (Sillence and Rimoin 1978) 
 
Types V-VII share phenotypic characteristics with types I-IV, in addition to each having 
some distinguishing traits. These OI types are associated with normal teeth and sclerae. 
Diagnosis is made on the basis of clinical and bone histological findings, and mutation 
analysis (Roughley et al. 2003). Type V OI is of unknown etiology. The distinguishing 
histology is lamellar organization of bone into irregular mesh-like appearance. Type V OI 
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is associated with hyperplastic callus formation at fracture sites and calcification of 
intraosseous membrane between the bones of the forearm. A dense band is seen on a 
radiograph adjacent to the growth plate of the long bones, and radial head dislocation is 
also typically seen. (Glorieux et al. 2000, Fassier et al. 2007, Cheung et al. 2008)  
 
The defining feature of type VI OI is an abnormal histologic lamellation pattern with fish-
scale like appearance of the bone lamellae and the presence of excessive osteoid. This OI 
type is moderate in severity with vertebral body involvement. No Wormian bones or 
rhizomelia are usually present. (Roughley et al. 2003, Bishop 2010, Homan et al. 2011) 
Type VII OI patients exhibit varying phenotypes from moderately deforming to lethal. 
Typical clinical findings are short humeri and femur. Type VIII OI is associated with 
extremely low BMD, severe growth deficiency, and bulbous metaphyses. Typical 
radiological findings in childhood are popcorn-like bone structures. Type IX OI patients 
display a phenotype varying from moderate to lethal. (Bishop 2010, Forlino et al. 2011) 
Type XI OI is also called Bruck syndrome 1. It has been reported in single Turkish and 
Mexican families (Alanay et al. 2010, Forlino et al. 2011). Other syndromes and disorders 
with overlap in phenotypic features with OI include Cole-Carpenter syndrome and Ehlers-
Danlos syndrome. 
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Table 1 Classification of OI. 
Type Inheritance Gene defect Phenotype 
I AD 
COL1A1 or 
COL1A2 
Non-deforming 
II AD 
COL1A1 or 
COL1A2 
Perinatally lethal 
III AD 
COL1A1 or 
COL1A2 
Severe deformity, rhizomelic dwarfism 
IV AD 
COL1A1 or 
COL1A2 
Moderate deformity, slightly shortened height 
V AD ? 
Moderate to severe deformity, hyperplastic callus, 
mineralised intraosseous memebrane.  
VI AR SERPINF1 Moderate deformity, abnormal bone architecture 
VII AR CRTAP 
Severe to lethal osteochondrodysplasia and 
rhizomelic dwarvism 
VIII AR LEPRE1 Severe to lethal osteochondrodysplasia 
IX AR PPIB Moderate to lethal deformity 
X AR SERPINH1 Severe to lethal deformity 
XI AR FKBP10 Progressive deformity 
 
2.3.3. Treatment 
As no cure for OI currently exists, treatment is multidisciplinary and aimed at preventing 
and controlling symptoms, as well as maintaining good life quality. This can be achieved 
by non-surgical management, such as physical therapy, bracing and splinting, surgical 
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management, such as intramedullary rods and spinal surgery, and/or medico-
pharmacological management. 
 
Medication treatment is either aimed at reducing bone resorption or enhancing bone 
formation. Currently bisphosphonates are virtually the drug of choice at least in the severe 
OI forms. They decrease bone turnover by inactivating osteoclasts and inducing their 
apoptosis thus increasing bone mass. Several observational studies have reported on the 
benefits of bisphosphonate treatment in patients with OI since 1998 (Åström and 
Söderhäll 1998, Glorieux et al. 1998, Phillipi et al. 2008, Vuorimies et al. 2011, Ward et 
al. 2011). Reported benefits include increased BMD, reduction in fracture rate and 
deformities of long bones, decreased bone pain, increase in the mean cortical width and 
vertebral size, and increased mobility (Plotkin et al. 2000, Roughly et al. 2003, Rauch et 
al. 2006, Bishop et al. 2010, Semler et al. 2011). More benefits are gained with severely 
affected patients than with the milder OI forms. The optimal dose and duration of 
bisphosphonate treatment remains to be determined. At present, maximum gain seems to 
be obtained after 2-4 years of treatment during growth (Rauch et al. 2006). 
Bisphosphonates are well tolerated. An acute phase reaction has been reported with first 
exposure. The long-term effects of accumulated bisphosphonates are, however, uncertain. 
 
Attempts to aid bone formation with growth hormone and parathyroid hormone therapy 
have been unconvincing in patients with OI. Vitamin D and calcium intake needs to be 
monitored during growth and supplemented when necessary. Stem cell and enzyme 
replacement therapy might become an alternative treatment in the future. (Monti et al. 
2010) 
2.4. Basilar pathology 
Basilar pathology refers to anomalies of the cranial base and/or craniocervical junction 
that cause neural compression and/or vascular compromise. In these conditions, brain stem 
compression can lead to neurological symptoms and other symptoms, such as 
hydrocephalus and macrocephaly, resulting from the prevention of cerebrospinal fluid 
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circulation (Charnas and Marini 1993, Sawin and Menezes 1997). Basilar pathology can 
be caused by dysplasia, malformation or deformation (Spranger et al. 1982). 
 
In the literature, early reports on basilar pathology date back to 1790 (Ackermann 1790). 
Subsequently Chamberlain drew wider attention to these pathologic conditions with his 
work on Bantu Africans (1939) suggesting that in healthy individuals atlas and axis should 
lie caudal to the “base line” drawn from the dorsal margin of the hard palate to the 
posterior edge of the foramen magnum, also called opisthion. McGregor introduced a 
reference line modified from that of Chamberlain’s in 1948, running from the upper 
surface of the posterior edge of the hard palate to the most caudal point of the occipital 
curve (McGregor 1948). His reasoning for the new reference line was that the lowest point 
on the occipital curve is easier to locate from a lateral skull radiograph than the opisthion 
point. Bull later confirmed the increased reliability, expressed as smaller variation in 
results, when McGregor’s reference line was used instead of Chamberlain’s. Bull also 
concluded that, when assessing basilar pathology in adults, age is an insignificant variable. 
Instead he found a gender difference in normal values (Bull et al. 1955). 
 
Pathological conditions of the cranial base and craniocervical junction are divided into 
basilar invagination, basilar impression, and platybasia (Figure 6). Sillence proposed the 
nomenclature to describe these entities that can occur simultaneously or as isolated 
findings. (Sillence 1994, Kovero et al. 2006) In several studies the terms have been used 
synonymously making comparison of results difficult. 
 
Diagnosis of basilar pathology can be made from a lateral skull radiograph, or from mid-
line sagittal MR or CT image, because all but one reference line commonly used in the 
literature are situated at the midsagittal plane: Chamberlain’s line (Chamberlain 1939), 
McRae’s line (McRae 1953), McGregor’s line (McGregor 1948), the anterior cranial base 
angle, DM distance (Kovero et al. 2006), Ranawat’s line (Tassanawipas et al. 2005), 
Wackenheim’s clivus baseline, the clivus-canal angle, Bull’s angle, and Landzert’s angle,  
(Smoker 1994). The atlanto-occipital joint axis angle is measured from an antero-posterior 
or coronal view of the skull (Smoker 1994). Cronin et al. (2009) demonstrated a similarity 
of results using the different imaging modalities with Chamberlain, McGregor, and 
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McRae’s measures. MR image is ideal for the evaluation of soft tissues, neural structures, 
and ligaments. CT images, on the other hand, provide excellent images of the osseous 
structures. Traditional radiographs are recommended as an initial screening method of 
basilar pathology, and in epidemiologic studies (Janus et al. 2003, Kovero et al. 2006). In 
case of a pathological finding in a lateral skull radiograph, CT scan or MR imaging should 
be conducted (Menezes 2008b). The advantages of plain radiographs include low radiation 
dose compared to a CT scan, low cost, easy accessibility, and short exposure time, making 
it simple for the patient. 
 
Basilar pathology can be symptomless or cause a spectrum of symptoms varying in impact 
and strength. Possible symptoms include motor myelopathy, sensory abnormalities, brain 
stem or lower cranial nerve dysfunction, vascular compromise, and basilar migraine. 
Motor myelopathy can be non-specific, manifesting as a lack of endurance or as paresis. 
Sensory abnormalities include posterior column dysfunction, hyperalgesia, and bladder 
dysfunction. Brain stem dysfunction can be expressed as nystagmus, apnea, ataxia, or 
dysmetria. Lower cranial nerve dysfunction presents often as dysphagia, soft palate 
paralysis, or trapezius muscle weakness. Symptoms of vascular compromise are syncope, 
vertigo, and intermittent paresis. Basilar migraine pain is documented in 25% of children 
with basilar invagination. (Hayes et al. 1999, Menezes 2008c, Smoker and Khanna 2008) 
The physical appearance of patients often includes a relatively short neck and restricted 
neck movement (Pearce 2007). Basilar pathology can also lead to respiratory arrest and 
sudden death (Sawin and Menezes 1997). 
2.4.1. Pathology of craniocervical junction 
Craniocervical junction anomalies are congenital osseous, developmental, or acquired 
abnormalities of the occipital bone, foramen magnum, or the first two cervical vertebrae. 
First, congenital structural abnormalities include anomalies of the atlas often involving the 
posterior arch, such as complete or partial aplasias, hypoplasia, and clefts, as well as 
anomalies of the axis. Odontoid hypoplasia is a rare condition ranging in severity from 
presence of rudimentary dens to complete aplasia (Menezes 2008b). Occipital bone 
anomalies include basiocciput hypoplasia, also called short clivus, occipital condyle 
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hypoplasia, and atlantooccipital segmentation failure, also termed occipitalization of the 
atlas. These anomalies are often associated with basilar impression and basilar 
invagination. Second, developmental anomalies can be secondary to systemic disorders 
that affect skeletal growth and development. Finally, primary acquired abnormality is the 
result of local bone destruction caused by, for example, a tumour or trauma. (Menezes 
1998, Smoker and Khanna 2008) 
2.4.1.1. Definitions and measurements 
Pathology of the craniocervical junction can be divided into basilar invagination and 
basilar impression. Basilar invagination is defined as the protrusion of the uppermost 
vertebral structures into foramen magnum. Definition of basilar impression, in contrast, is 
a relative lowering of the cranial base with consequent positioning of the uppermost 
vertebral structures above the caudal border of the skull. 
 
Basilar invagination is commonly evaluated by measuring the perpendicular distance of 
the tip of the odontoid process to McRae’s reference line, also called the foramen magnum 
line, that extends from the anterior to the posterior edge of foramen magnum, that is from 
basion to opisthion (Figure 1, Study I) (McRae 1953). Basilar invagination is diagnosed 
when the tip of the odontoid extends above the McRae’s line, thus the measure is positive 
(McRae 1953, Kovero et al. 2006). 
 
Basilar impression can be evaluated by measuring the perpendicular distance of the tip of 
the odontoid process to Chamberlain’s line or McGregor’s line, or by measuring the D-M 
distance (Chamberlain 1939, McGregor 1948, Kovero et al. 2006). The reference line to 
measure D-M distance is a line parallel to the nasion-sella line passing through the lowest 
point of the occipital curve (Figure 1, Study I). This reference line was first introduced in 
Kovero et al. (2006) to obtain a reference level more stable in OI patients than the one 
involving the posterior nasal spine. Several values have been suggested as a threshold 
limit of pathology (McGregor 1948, Hayes et al. 1999). Kovero et al. (2006) revised the 
threshold limits of the Chamberlain measure by more than 10.5 mm, of the McGregor 
measure by more than 11.9 mm, and with a vertical D-M distance more than 9.4 mm as 
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diagnostic radiological criterion for basilar impression in the adult population. These 
values are 3 standard deviations above average of healthy controls. The group further 
suggested that patients, whose value exceeds that of healthy controls by 2 standard 
deviations, warrant further examination. 
 
Other measurements, more rarely used in literature, to evaluate craniocervical junction 
pathology include the Ranawat measure, which is the perpendicular distance between the 
centre of the sclerotic ring of C2 and a line drawn along the antero-posterior axis of C1 
(Tassanawipas et al. 2005), Bull’s angle, which is the intersection of the hard palate and 
the plane of the atlas (Bull et al. 1955), and Wackenheim clival line, which is a line drawn 
along the superior surface of the clivus. Protrusion of the odontoid posterior to the line’s 
projection is considered a pathological finding (Thiebaut et al. 1961). 
2.4.2. Platybasia 
2.4.2.1. Definitions and measurements 
Platybasia is defined as the flattening of the skull base, and is often associated with 
craniocervical junction pathology (Pearce 2007). It is infrequently accompanied by a 
developmentally shortened clivus (Pang and Thompson 2011), however platybasia can be 
asymptomatic and therefore its clinical significance is disputed (McRae 1953). 
 
Platybasia is commonly assessed by measuring the anterior cranial base angle, which is an 
angle between the nasion-sella and sella-basion lines. Nasion is defined as the most 
anterior ventral point of the suture between the frontal and nasal bones, whilst sella is the 
midpoint of the pituitary fossa. McGregor considered an angle above 148 degrees to be 
highly suggestive of platybasia in young adults (McGregor 1948), whilst Kovero et al. 
(2006) set the threshold limit at 146 degrees for adults. 
 
Another, more rarely used, measure to evaluate platybasia is the NTB angle of Welcker 
that joins the nasion, tuberculum sellae, and basion (Pang and Thompson 2011). 
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2.4.3. Basilar pathology in OI 
A wide range of craniofacial morphology is observed in OI, from nearly normal to severe 
dysmorphology (Waltimo-Sirén et al. 2005). Typical radiographic findings include a 
generalized decrease in density and thickness of calvarial bones. Delayed closure of 
fontanelles and sutures, and excessive Wormian bone formation might also be visible. 
(Hayes et al. 1999) Intersutural Wormian bones are most evident along the lambdoid 
suture, which connects the parietal and temporal bones with the occipital bone on the 
posterior aspect of the skull (Cremin et al. 1982, Glass et al. 2004). Extremely 
osteoporotic bone might in some cases make diagnosis of basilar pathology challenging 
from a plain radiograph (Janus et al. 2003). 
 
The pathogenesis of craniocervical anomalies in OI remains obscure. Anomalies have 
been observed in OI types I, III, and IV, but not in the perinatally lethal type II (Sawin and 
Menezes 1997). A generally accepted hypothesis is that craniocervical junction anomalies 
are caused by skeletal dysplasia and force induced deformation. The weight of the brain 
compresses the cranial base, causing microfractures that result in relative upward 
migration of the craniocervical structures (Figure 6) (Frank et al. 1982, Sillence 1994). 
Findings reported by Sawin and Menezes (1997) support this hypothesis; they report a 
frequent intraoperative finding of thickened proliferative bone that resembles callus in the 
skull base. 
 
In patients with OI, basilar impression has been noted to be a more frequent finding than 
basilar invagination (Hayes et al. 1999). Reported symptoms of craniocervical junction 
pathology in patients with OI include Chiari malformation (herniation of the cerebellum 
through the foramen magnum), hydrocephalus, and other consequences of compression of 
brain stem and related structures by bone or soft tissues. Symptoms can also result from 
indirect compromise of the blood supply. (Frank et al. 1982, Sawin and Menezes 1997, 
Charnas and Marini 1993, Smith et al. 2010) Sudden infant death has also been reported 
following respiratory or cardiac failure (McAllion and Paterson 1996, Menezes 1997). 
Basilar invagination, clinically exhibited as short neck, has been associated with the 
occurrence of sleep apnea in patients with OI (Li et al. 2002). In severe forms of the 
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disorder, macrocephalia has been described (Charnas and Marini 1993, Primorac et al. 
2001). 
 
The prevalence of basilar invagination or basilar impression has been studied in children 
and adults with types I, III, and IV OI (Table 2). The prevalence figures range from 0-
100% in type I, 18-100% in type III, and 4-71% in type IV (Charnas and Marini 1993, 
Sillence 1994, Jensen and Lund 1997, Engelbert et al. 1998, Janus et al. 2003, Kuurila et 
al. 2003, Kovero et al. 2006). The medication status of the patients has not been reported 
in these articles. Studies on paediatric patients report the onset of craniocervical pathology 
from the age of 2 to 3 years onwards (Rush et al. 1989, Sillence 1993). In concordance 
with these studies, basilar pathology has been suspected to be progressive in patients with 
OI (Charnas and Marini 1993, Sillence 1994, Kovero et al. 2006). 
 
Figure 6 Radiograph of a female aged 13.5 years with type III OI exhibiting basilar impression 
and platybasia in the absence of basilar invagination. McRae’s line and D-M 
distance line are indicated in black, and the anterior cranial base angle in white. 
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Table 2 Prevalence of basilar pathology in different OI types 
Author 
Age of 
patients 
(years) 
Type I 
n/N(%) 
Type III 
n/N(%) 
Type IV 
n/N(%) 
Criteria for 
abnormality 
Charnas & Marini 
1993 
0.3-65 0/4(0) 6/33(18) 2/31(6) 
McRae >0 
McGregor >5mm 
Sillence 1994 NA (10-100) (30) (5-71) 
Chamberlain >5mm 
McGregor >7mm 
Jensen & Lund 1997 13-62 1/35(3) 4/4(100) 5/13(38) 
Chamberlain >5mm 
McGregor >7mm 
Engelbert et al. 1998 1-16 0/17(0) 7/16(44) 1/14(7) 
McGregor  (threshold 
value not reported) 
Janus et al. 2003 0-18 0/85(0) 7/21(33) 1/24(4) 
Chamberlain and 
McGregor (threshold 
values not reported) 
Kuurila et al. 2003 19-69 3/21(14) 2/5*(40) 4/15(27) 
McRae >0 
Chamberlain >10mm 
Kovero et al. 2006 16-69 4/29(14) 3/5(60) 7/19(37) 
McRae >0   
D-M distance >9.4mm 
n = number of patients with pathological finding 
N = total number of patients in the study 
NA data not available 
* one patient was either of type III or IV 
2.4.4. Basilar pathology in other disorders 
As stated earlier, primary basilar pathology can result from congenital structural 
anomalies. Atlantooccipital fusion, or occipitalization of the atlas, is the most common 
congenital abnormality of the upper cervical spine. The incidence is around 0.25% in the 
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general population (Menezes 2008c). Atlantooccipital fusion refers to partial or complete 
congenital fusion between the atlas and the base of the occiput resulting in an increased 
risk of atlantoaxial instability. The severity ranges from a complete bony fusion to a 
fibrous band. Atlantooccipital fusion is a result of segmentation failure between the fourth 
occipital sclerotome and the first spinal sclerotome, as in Klippel-Feil syndrome. 
(Menezes 1998, Gholve et al. 2007, Smoker and Khanna 2008) 
 
The majority of axis anomalies are associated with os odontoideum, which is defined as a 
failed fusion between the tip of the odontoid and the body of C2. The base of the dens is 
often hypoplastic. (Smoker and Khanna 2008) While the exact etiology is unclear, os 
odontoideum is believed to result from a childhood trauma or a fusion failure of the base 
of odontoid. This anomaly is often asymptomatic, and thus only incidental radiographic 
findings of a separate ossicle moving with the clivus or anterior arch of the atlas are seen. 
The ossicle may, in fact, fuse with the clivus. The condition may also be revealed with the 
onset of symptoms following minor trauma. Os odontoideum can cause atlantoaxial 
instability and compression of the spinal cord. (Menezes 1999) Increased incidence of os 
odontoideum has been found in Down syndrome, Morquio syndrome, spondyloepiphyseal 
dysplasia, Klippel-Feil syndrome, and Larsen syndrome (Smoker and Khanna 2008). 
 
Secondary developmental basilar anomalies, as in OI, have also been described in 
achondroplasia, spondyloepiphyseal dysplasia, Morquio syndrome, chondro-
osteodystrophy, cleidocranial dysostosis, Goldenhar syndrome, Larsen syndrome, Weaver 
syndrome, Paget’s disase, rheumatoid arthritis, rickets, hyperparathyroidism, and 
osteoporosis (Charnas and Marini 1993, Menezes 2005, Menezes 2008c). An increased 
incidence of atlantoaxial dislocation, possibly leading to basilar invagination, in 
occasional patients with Down syndrome, is due to ligamentous laxity (Uno et al. 1996). 
Similar occipitoatlantoaxial instability and increased incidence of basilar invagination are 
seen in Ehlers-Danlos syndrome and in some mucopolysaccharidoses, such as Morquio 
syndrome. In achondroplasia, on the other hand, the aetiology of craniocervical anomalies 
lies within underdevelopment of the skull base. (Milhorat et al. 2007, Smoker and Khanna 
2008) 
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2.4.5. Treatment 
Treatment of craniocervical junction pathology involves either non-operative approaches 
with skeletal halo traction, or operative approaches, with or without preoperative halo 
traction. The primary goal is to relieve compression at the craniocervical junction. When 
operative treatment is needed, generally either posterior decompression of the foramen 
magnum or anterior transoral-pharyngeal decompression is conducted, followed by 
occipitocervical fusion. Good long-term outcomes with sustained benefit in 60% of 
patients have been achieved with such decompression surgery and dorsal stabilization. 
(Kurimoto et al. 1991, Ibrahim and Crockard 2007, Menezes 2008d) Annual clinical 
examination, including neurological, and radiological follow-up, are recommended for 
surgically treated patients to monitor for possible recurrence of pathology (Sawin and 
Menezes 1997). 
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3. Aims of the study 
The aim of this study was to analyse the morphology and developmental changes in the 
cranial base and craniocervical junction in an unselected control population and in patients 
with OI. 
 
The following specific aims were set for the present study:  
 
1 To analyze the reliability of identification of anatomic landmarks on lateral 
skull radiographs based on which craniocervical junction dimensions can be 
measured (I). 
2 To explore whether any of the commonly used measurements of cranial base 
or craniocervical junction is less sensitive to errors than the others (I). 
3 To study changes in the vertical dimensions of the craniocervical junction, 
and in the flexion of the anterior skull base in healthy individuals during 
growth (II). 
4 To define diagnostic criteria for basilar anomalies in growing individuals 
(II). 
5 To analyze the prevalence and clinical and genetic correlates of 
craniocervical junction anomalies in growing OI patients (III, IV). 
6 To explore the natural course of development of basilar anomalies in 
growing OI patients (IV). 
7 To establish guidelines for radiologic screening and follow-up of 
craniocervical junction area in patients with OI (IV). 
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4. Materials and methods 
4.1. Diagnostic images 
The study was based on lateral images of the skull. Lateral skull radiographs, MR, and CT 
images of the midsagittal plane were used. Radiographs had been taken with the central X-
ray passing through the porion-porion axis and head position fixed with ear rods in 
cephalostat whenever possible. 
4.1.1. Normal population cohorts 
The subjects were a sub-sample of 248 individuals participating in a Longitudinal Growth 
Study, conducted on an unselected sample of healthy ethnic Finns (Caucasian Europeans) 
between 1967 and 1993 at the Institute of Dentistry, University of Helsinki, Finland. 
Subjects were randomly selected from those with a longitudinal series of at least five 
lateral skull radiographs obtained during growth (Table 3). Cut-off age was set at 25 years, 
up to which vertebral body growth has been reported to normally occur (reviewed by 
Harrison et al. 1977). The changes in craniocervical junction dimensions during growth 
were assessed for a mean observation period of 16.0 years (range 10.1 to 20.8 years). 
 
For study IV, images of additional 15 healthy children, aged 0-3 years, were analysed 
(Table 3 and Figure 7). The children had been examined at the Children’s Hospital, 
Helsinki University Central Hospital, for suspected accidental skull fractures possibly 
affecting calvarial or facial, but not skull base structures.  
 
In study II the radiographs were grouped according to gender and age for analysis. In 
studies III and IV the healthy subjects were divided into two-year age groups that were 
age-matched with the patient cohort. 
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Table 3. Number of subjects and images comprising the material of this thesis 
Publication Controls OI patients Total 
number of 
images 
Age range 
(years) 
 A B C D   
I 23    23 4.5-24.9 
II 53    308 3.4-25.7 
III 191  187  440 3.4-59 
IV 53 15  76 474 0-39.1 
A Helsinki Longitudinal Growth Study, Finland 
B Young children, Helsinki University Central Hospital, Finland 
C Shriners Hospital for Children, Canada 
D Helsinki University Central Hospital, Finland 
 
Figure 7 Age and gender distribution of control and patient cohorts (IV). 
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4.1.2.  OI patient cohorts 
Diagnosis of OI in all of the patients included in studies III and IV was based on clinical 
features, appropriate family history and/or identification of a mutation in the genes 
encoding type I collagen. In study III, the patient population comprised individuals with a 
clinical diagnosis of OI, who were examined at the Shriners Hospital for Children in 
Montreal, Canada. Of the 187 patients, 96 were female and 91 were male. When more 
than one skull radiograph of a single patient was available, the most recent one was used 
for the cross-sectional analysis. For the 62 patients (33%) with several available 
radiographs, the first and most recent ones were used for longitudinal analysis. 
 
In study IV, all clinically diagnosed OI patients were included, examined at the Institute of 
Dentistry, University of Helsinki and/or Children’s Hospital, Helsinki University Central 
Hospital, of whom an initial lateral skull radiograph or MR image had been obtained 
before the age of 25 years. Altogether 76 patients, 39 females and 37 males, from 69 
families, met the inclusion criteria. Longitudinal data were available from 31 patients 
(41%). The first available image of each patient was used for cross-sectional analysis. In 
total, 143 radiographs and 7 MR images were analyzed. Table 4 displays the distribution 
of the OI types as well as selected clinical characteristics of the patients. 
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Table 4. OI type and clinical characteristics of the patient cohorts in studies III and IV. 
OI type I III IV V* VI* VII* 
Study III IV III IV III IV III III III 
N 88 47 30 13 51 16 11 4 3 
Height  
(Z-score) 
-1.2 -1.2 -6.7 -6.3 -3.5 -4.0 -2.6 -4.4 -2.1 
aBMD  
(Z-score) 
-2.3 - -3.3 - -2.6 - -2.0 -1.9 -2.1 
Dentin 
dysplasia (%) 
17 - 87 - 51 - 0 0 0 
Blue sclerae 
(%) 
82 - 80 - 57 - 18 0 0 
Wormian 
bones (%) 
36 - 100 - 82 - 73 0 67 
Bisph tx (%) 46 5.4 93 30.8 96 50 82 100 100 
Scoliosis (%) - 3.3 - 69.2 - 53.8 - - - 
Head 
circumference 
(Z-score)  
- -0.2 - -0.1 - 0.8 - - - 
* No patients of this type in study IV 
4.2. Radiographic measurements 
Magnification at the midsagittal plane was calculated for each image according to the 
distance of the patient from the film and X-ray tube, then linear measurement values were 
corrected to natural size. When radiographic magnification was unknown, only angular 
measures were used, in addition to McRae’s linear measurement as positive or negative. 
 
Two examiners together identified 7 cephalometric landmark points on all of the images 
(Figure 8). Measurements from traditional radiographs were obtained with a hand ruler to 
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the closest 0.5mm distance or 0.5 degrees (°) angle (I, II, IV). Digital radiographs and MR 
images were analysed using a specially programmed algorithm in Viewbox software 
(version 3, dHal, Kifissia, Greece) (IV). In study III, the measurements were made to the 
closest 1mm or 1° from the average result of two independent observers. 
 
In studies I-IV, the nasion (N), sella (S), and basion (Ba) points were located to measure 
the anterior cranial base angle. In studies I-III, the other points were traced to measure the 
perpendicular distance from the odontoid process (D) to four previously described 
reference lines;  
1. McRae’s line (Ba-Op) 
2. Chamberlain’s line (PNS-Op) 
3. Modified McGregor’s line (from posterior edge of the hard palate to the lowest 
point on occipital curve, PNS-M) 
4. D-M distance 
 
In study IV, the distance of the dens from the reference line of McRae, D-M distance, and 
the novel D-M angle were measured. D-M angle was defined as the angle between a line 
running through the lowest point of the occipital curve parallel to the sella-nasion line (as 
for D-M distance), and a line drawn from tip of the dens to the lowest point of occipital 
curve (Figure 8.). The linear measurements were considered positive when the dens point 
lay above the reference line, and the D-M angle when the line connecting dens and the 
lowest point on occipital curve was situated above the line running through the lowest 
point of occipital curve parallel to the sella-nasion line. 
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Figure 8 Cephalometric landmarks, reference lines, and angular measurements used. 
Landmarks in alphabetical order were Ba (basion), D (dens), M-point, N (nasion), 
Op (opisthion), PNS (posterior nasal spine), S (sella turcica). Numbered reference 
lines and angular measurements were; 1.McRae’s line 2. Chamberlain’s line 3. 
McGregor’s line 4. D-M distance 5. D-M angle 6. Anterior cranial base angle. 
The following definitions and diagnostic criteria were used: 
o Basilar invagination was diagnosed when McRae measure was at or above 0. 
o Basilar impression was diagnosed when Chamberlain measure, McGregor measure, or 
D-M distance were more than 3 SD above the average of age-matched healthy controls 
(III). In study IV, the criteria for screening patients for further evaluation with a MR or 
CT scan was lowered to a D-M distance or D-M angle more than 2.5 SD above the 
average of age-matched healthy controls. 
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o Platybasia was diagnosed when the anterior cranial base angle was more than 3 SD 
above control average in study III, and more than 2.5 SD in study IV, above the 
average of healthy controls.  
o Patients who received at least one of these diagnoses, were considered to have a 
cranial base anomaly. 
4.2.1. Intra- and interexaminer error 
Two examiners analysed 20 lateral skull radiographs, and 11 examiners 3 radiographs 
independently, to assess the intra- and interexaminer error in landmark identification (I). A 
sensitivity analysis was conducted, with the results of the most experienced examiner as a 
reference, to test the impact of the difference in the location of a single landmark on the 
measurements. This was done to simulate the clinical situation where an examiner, 
previously unfamiliar with the method, starts using it. Another purpose was to compare 
the sensitivity of the different measurements to errors. 
4.3. Other measurements 
Height, weight, and head circumference measurements were converted to age- and sex-
specific Z-scores (III, IV), as well as lumbar spine (L1-L4) areal bone density (LS aBMD), 
as determined by DXA in the posteroanterior direction (III). 
4.4. Statistical methods 
Primary statistical tools were mean, standard deviation (SD), and range. Nonparametric 
statistics were applied when the data were not normally distributed. To test the reliability 
of cephalometric landmark identification, based on which the craniocervical junction 
dimensions are measured, the reproducibility of these landmark points was analysed using 
the Dahlberg’s formula on repeated measurements (I). Dahlberg’s formula combines 
systematic and random components of the error, and includes the assumption that the two 
determinations are made independently of each other (Dahlberg 1940). 
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Spearman’s Rank Correlation test was used to calculate correlations between the 
measurements in the control cohort. One-way analysis of variance (ANOVA) was 
performed for each measurement to test whether the mean values of the age groups 
differed significantly. Mann-Whitney test was used to test differences between the 
measurements of males and females. P values less than 0.05 were considered statistically 
significant. (II) 
 
Pearson's correlation coefficient was used to evaluate the correlation between D-M angle 
and D-M distance (IV). 
 
Logistic regression analysis was used to evaluate the relationship between patient 
characteristics and the presence of cranial base abnormalities (III, IV). Potential predictor 
variables were age, gender, and height Z-score (III, IV), as well as OI type (type I, III or 
IV), intravenous bisphosphonate treatment history, weight, presence of dentin dysplasia 
(dentinogenesis imperfecta) or blue sclerae, and type of collagen type I gene mutation 
(III). Bisphosphonate treatment status at the time of imaging and craniocervical junction 
pathology were included as dichotomous variables (yes/no). 
 
Calculations were performed using PASW Statistics software version 17.0 for Windows 
(SPSS, Inc., Chicago, IL, USA) and R language (version 2.13.0, R Development Core 
Team, R: A Language and Environment for Statistical Computing, Vienna, Austria, 2008). 
4.5. Ethical considerations 
Informed consent was obtained from all of the participants, or their legal guardians, for the 
Helsinki Longitudinal Growth Study. Images of patients with OI had been originally taken 
for diagnostic and/or treatment purposes and were thus justified. The ethics committee of 
the Institute of Dentistry, University of Helsinki, the Joint ethical committee of Helsinki 
University Central Hospital, and Shriners Hospital Institutional Review Board have 
approved these studies. 
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5. Results 
5.1. Validation of methods 
The distribution of landmarks in this study, determined independently by several 
examiners, was not random but systematic, following the anatomic form of the identified 
structure. The magnitude of difference in the landmark identification was dependent on 
the landmark in question. Inter- and intraexaminer errors were of a similar magnitude, 
although intraexaminer error declined in the repeated landmark identification. The extent 
to which variation in landmark identification affected the measurement results differed 
from landmark to landmark. Sensitivity analysis revealed that variation in the location of a 
landmark affected the linear measurement values on average less than the actual shift. In 
contrast, age of the subject did not affect the magnitude of random error. (I) 
 
Of the linear measurements, the McGregor measure exhibited the smallest inter-examiner 
variation (SD on average 1.1 mm), and was least sensitive to errors in landmark 
positioning. McRae’s measure, in contrast, displayed the largest interexaminer variation, 
and was the most sensitive to changes in landmark positioning. Notably, however, the 
basilar invagination diagnosis, based on McRae’s measure, simply requires that dens 
vertically exceeds McRae’s line, that is, the measure value is either positive or negative. 
Importantly, despite the inter-examiner variation, none of the consecutive results of the 
linear measurements or the anterior cranial base angle would have led to a false positive 
clinical diagnosis. (I) 
 
In study III, D-M measure was confirmed to be a more sensitive indicator of basilar 
impression in patients with OI than Chamberlain or McGregor measures. 
 
In study IV, a new angular measure, D-M angle, was constructed to overcome the need to 
correct the radiographic magnification. To obtain reference values for the novel D-M 
angle measure, the angle was calculated on 290 radiographs of a longitudinal series in a 
subgroup of 65 subjects (aged 0-26) from the control cohort. Correlation analysis 
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indicated a statistically significant positive relationship between D-M angle and D-M 
distance (r=0.980, 95% CI: 0.967-0.990; P<0.01, n=290), which suggests that D-M angle 
may be applicable as a measure of basilar impression. 
5.2. Basilar structures in normal population 
In young children, the tip of the odontoid process is situated relatively more caudally in 
relation to the skull base structures and reaches a level similar to that of adults by 7 years 
of age in both males and females. This age-related change was most evident with the 
McRae measure and least conspicuous in D-M distance. Therefore, it can be concluded 
that growth-related changes in the craniocervical junction have a tendency to bring the 
odontoid process and skull base closer to each other. Individual variation is notable, both 
in the distance of dens from the reference lines and in the direction of growth-related 
changes. In some subjects, the measures increased during growth, while in others they 
decreased, or periods of increase and decrease alternated. No specific age at which these 
changes occurred could be determined. This individual variation was camouflaged in the 
cross-sectional analysis. (II) The D-M distance increased in 43% of subjects, decreased in 
55%, and remained constant in 2% of subjects with age (II). A decrease was evident in the 
anterior skull base angle during growth before the age of three years (II, III, IV). Table 5 
displays the age specific measurement results for selected parameters. 
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Table 5. Normal values for selected cranial base measures in different age groups. The 
mean, minimum, and maximum values are given for each parameter. 
Age group 
(years) 
 0-2 3-4 5-6 7-8 >9 
McRae 
measure 
(mm) 
Mean NA -5.1 -7.2 -5.1 -4.5 
 
Min  
Max 
NA 
-7.6 
-3.3 
-13 
-2 
-9.4 
-1 
-10 
-1 
D-M angle 
(degrees) 
Mean -6.9 0.7 -7 -2.4 -3.4 
 
Min 
Max 
-23 
3 
-5 
8 
-23 
7 
-14 
9 
-24 
11 
Anterior 
cranial base 
angle 
(degrees) 
Mean 136 130 131 130 129 
 
Min  
Max 
131 
147 
116 
136 
116 
139 
123 
140 
121 
139 
NA data not available 
 
The McRae measure was negative in all controls at all ages, indicating that the odontoid 
process was situated below foramen magnum level (II, III, IV). Similarly, none of the 
control subjects exceeded the clinical screening limit (+2.5 SD from the average) of 
platybasia or basilar impression (II). The age group means for linear measurements were 
similar in females and males, with only a few exceptions (II, III). In subsequent studies, 
the results of both sexes were pooled to ensure an adequate sample size for each age 
group. Based on these figures for normal development we constructed diagnostic age-
dependent criteria for basilar impression and platybasia (Table 6).  
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Table 6. Threshold values of anomaly. D-M distance, D-M angle, and anterior cranial base 
angle threshold values set at +2.5 SD from the normal average of each age group. 
Age-group 
(years) 
0-2 3-4 5-6 7-8 ≥9 
D-M 
distance 
(mm) 
NA 8.8 7.1 6.9 7.4 
D-M angle 
(degrees) 
10.8 14.3 13.0 11.7 12.4 
Anterior 
cranial base 
angle 
(degrees) 
146 146 143 141 143 
NA data not available 
5.3. Basilar structures in OI 
5.3.1. Cross-sectional analysis 
Craniocervical anomaly was found in all studied OI types. In study III, 41 patients (22%) 
had at least one cranial base anomaly (diagnostic level set at +3 SD). Isolated basilar 
invagination was found in 4 patients, isolated basilar impression in 7 patients, and isolated 
platybasia in 25. A combination of two of these conditions was evident in 4 patients 
(2.1%) and one patient with type III OI was diagnosed with all three. 
 
In study IV, the incidence was 37% (28 patients) for an abnormal finding, exceeding the 
+2.5 SD limit, in one of the three cranial base measures. In the cohort, 12 patients were 
diagnosed only with platybasia, 1 with isolated basilar invagination and 1 with isolated 
basilar impression. Of those with an abnormal finding, 44% displayed more than one type 
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of anomaly. Six patients, of whom one had type I, one type IV, and four type III OI, 
displayed all three pathological conditions. 
 
In study III, the analyses of the association between clinical characteristics and skull base 
anomaly were limited to a group of 169 patients with OI types I, III and IV, as the other 
OI types were too rare for detailed statistical evaluation. The presence of dentin dysplasia 
and Wormian bones were positively associated with occurrence of cranial base anomalies, 
whereas higher Z-scores of height, weight and LS aBMD as well as a diagnosis of OI type 
I were associated with lower odds for a cranial base abnormality. Age, gender, scleral hue, 
and a history of bisphosphonate treatment were not significantly related to the presence of 
anomalies (Table 4 in study III). The final regression model included only height Z-score 
as a significant independent determinant of cranial base anomalies (OR 0.53, 95% CI: 
0.43 - 0.66; P<0.001). In the group of patients with a height Z-score below -3, the 
prevalence of anomalies was similar to patients who had received pamidronate in the first 
year of life (8 of 17 patients corresponding a prevalence of 47%) and to patients who had 
received bisphosphonates at a later age or not at all (21 of 44 patients, prevalence 48%; 
P=0.96 by chi square test), indicating lack of evidence for a suspected protective role of 
bisphosphonates in the development of basilar pathology (III). The regression analysis in 
study IV gave similar results, indicating a higher risk of having any of the pathological 
condition with a lower height Z-score (OR 0.64, 95% CI: 0.45-0.85; P<0.004, for one SD 
unit), independent of age or gender. 
 
In study III, DNA sequence analysis was performed on 149 patients of whom 140 were 
positive for a mutation in COL1A1 or COL1A2. Among them, cranial base anomalies were 
present in 6% of those with haploinsufficiency (frameshift or nonsense) mutations, in 43% 
of those with helical glycine substitutions in COL1A1, in 32% of those with helical 
glycine substitutions in COL1A2, in 17% of those with splice-site mutations affecting 
either COL1A1 or COL1A2, in two of the five patients with C-propeptide mutations, and 
in one of the five patients with in-frame deletions. The type of collagen type I mutation 
was not independently associated with the prevalence of anomalies. (III) 
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The most prevalent diagnosis was platybasia (III, IV). In study III, platybasia was found in 
16% of patients, whereas basilar impression and basilar invagination were diagnosed in 
6% and 4% of patients, respectively. In study IV platybasia was present in 28.4% of 
patients, basilar impression in 14.9%, and basilar invagination in 13.2% of the patient 
cohort. Most of the Z-score values for cranial base measures were positive (above zero), 
indicating a relatively high position of the uppermost vertebral structures or flat cranial 
base (IV). Figures 4A,B, in study IV, display the cranial base measurement Z-scores of the 
cross-sectional patient analysis. Overall, in most measurements and age groups, the score 
was highest in type III OI, followed by type IV,and then type I, reflecting the general 
severity of the disorder. 
5.3.2. Longitudinal analysis 
In study III, cranial base anomaly was detected in nine patients (15%), as evaluated from 
the first available image. At the time of the last imaging, none of the 4 patients previously 
diagnosed with basilar impression fulfilled the criteria any longer. In contrast, platybasia 
persisted in all five patients originally diagnosed with it, and an additional seven patients 
had developed platybasia. Six patients had newly acquired basilar impression. Basilar 
invagination was not observed in the longitudinal patient group at either time point. 
 
Likewise, in study IV we observed no statistically significant progression of 
craniocervical junction pathology with age. Longitudinal series were available for 31 
patients of whom 25 had not been treated with bisphosphonates and were included in the 
final analysis. The beginning of series ranged from birth to 25 years. A normal McRae’s 
measure in the beginning of follow-up changed into a pathological one in two of the five 
type III OI patients and in all three of the type IV OI patients later fulfilling the criterion 
for basilar invagination. Similarly, basilar impression developed during the follow-up in 
two of the four type III OI patients and two of the three type IV patients. Platybasia 
developed during follow-up in one of the eight type III patients, and in the only type IV 
patient diagnosed with it. 
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Once detected, basilar invagination persisted throughout the follow-up in all type IV 
patients, whereas in two type III patients, McRae’s measure returned to normal at older 
age. Basilar impression persisted in the follow-up, with the exception of one type I patient, 
in whom the D-M angle measure returned to normal. Onset of basilar invagination and 
basilar impression was seen at all ages from 2 years onwards. Platybasia persisted in all 
the patients diagnosed with it (Figure 9). Platybasia was present from birth. Individual 
variation in measurement results was notable. (IV) 
 
In study IV, the number of patients treated with bisphosphonates (n=14) was too small for 
detailed statistical evaluation. Visual exploration of the developmental curves of the 
cranial base measurements revealed, however, no difference between patients treated and 
not treated with bisphosphonates. Analysis of individual patients revealed that basilar 
pathology emerged even after treatment with bisphosphonates. One or more radiographs 
were available for eight patients after the onset of medication. For five of these patients, at 
least one image had been obtained before the bisphosphonate treatment. Platybasia was 
first detected in four patients (one type I, two type III, and one type IV), who had received 
intravenous pamidronic acid infusion. In two of these patients platybasia was not present 
before the treatment. Treatment time ranged from 1 to 3 years with a dose of 0.5-1.0 
mg/kg per day, during 3 days, at 3 to 4 month intervals. One patient with type IV OI had 
initially normal craniocervical junction measure values, and developed basilar impression 
after 4 treatment episodes with zoledronic acid infusion. Platybasia improved in one type 
IV patient previously diagnosed with it, who had received intravenous pamidronic acid for 
1.5 years at 3-month intervals, and later 3 treatment episodes with zoledronic acid 
infusion. Similarly, basilar impression could no longer be diagnosed, while platybasia 
persisted in one type IV patient, who had received 6 treatment episodes with zoledronic 
acid. Zoledronic acid was administred with a dose of 0.05 mg/kg as a single infusion every 
6 months. One type IV patient acquired basilar invagination despite the treatment with 
pamidronic and zoledronic acid infusion for 3 years. The craniocervical status of this 
patient prior to medication was unknown. Despite the small sample of patients, similar 
tendencies in response to bisphosphonate treatment can be expected to appear universally 
in patients with OI. 
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A delay in the occurrence of symptoms following a radiological finding of cranial base 
pathology was observed in the study IV cohort. In the Finnish patient cohort, those with 
radiologically defined pathology were mostly free of clinical neurologic symptoms. One 
18 –year-old female with type III OI and both basilar invagination and impression suffered 
from numbness in the upper extremities. One 20 –year-old male with type III OI, and all 
three types of cranial base anomalies, reported basilar headache induced by coughing. He 
died shortly after of pneumonia. Another male, with type III OI, and all three types of 
anomalies, underwent decompression surgery and posterior stabilisation at the age of 8 
due to Chiari I malformation with a sole clinical symptom of muscle weakness in lower 
limbs first detected a year prior to surgery. He was the only one receiving treatment for the 
cranial base pathology (Figure 10). On detection of cranial base pathology, a MR scan and 
neurological examination were recommended for all patients. 
 
Figure 9 Cranial base measures (in millimetres or degrees) of patients not treated with 
bisphosphonates, according to OI type. Results include longitudinal follow-up and 
isolated findings with known radiographic magnification (IV). 
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Figure 10 Radiographs of a male with OI type III A) at birth and B-D) at ages 7.5, 8.5, and at 
11.7 years. The patient presented with platybasia from birth and developed basilar 
invagination and impression by 4 years of age. Surgical decompression and posterior 
fixation was conducted at the age of 8 years due to evolution of Chiari I malformation 
following the craniocervical anomalies. The patient had been treated with 
bisphosphonates from the age of 4.5 years. Image D obtained after the surgery was 
not used in the longitudinal analysis.  
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6. Discussion 
6.1. Reliability of observations 
The interpretation of radiographs, MR, and CT images invariably comprises some 
systematic and random errors, which can only be dealt with by repetitive analysis to a 
certain extent. Evaluation of the effect of the errors is vital for the reliability of 
observations. The observations made in this investigation suggest that, on average, 
variation in the location of a single landmark affects little the cranial base measurement 
values, whilst linear measurements and angles have been shown to be affected by the 
rotation of the head (Ahlqvist et al. 1986, Malkoc et al. 2005). For this reason, at the 
Institute of Dentistry, University of Helsinki, where the majority of the radiographs were 
obtained, images had been taken with ear rods stabilizing the positioning of the head and 
minimizing its rotation. Healthy individuals, old enough to stand independently in the 
cephalostat, and patients with OI, whenever possible, were positioned with the clinical 
Frankfurt horizontal plane parallel to the floor. Extension and flexion of the head have 
been shown, in contrast, to leave unaffected the distance of the tip of the odontoid process 
from the foramen magnum line (McGregor 1948). The cephalometric landmarks used in 
this study are located on the midsagittal plane, and thus the method is applicable, in 
addition to radiographs, to CT, and MR images of the same plane. An exception is the 
lowest point of the occipital curve, which might be visualised differently on a lateral skull 
radiograph and on MRI (Cronin et al. 2007). The lowest point is sometimes situated 
lateral to the midsagittal plane and thus is not visible on midline MRI. This can lead to the 
D-M measure reference line being located more caudally on a plain radiograph, and result 
in a more positive distance of the odontoid process to the reference line. The general 
reliability of the observations from a conventional radiograph were reported by Janus and 
co-workers (2003), who found that in all the studied cases, MRI findings confirmed the 
suspicion of pathology from a traditional radiograph in growing patients with OI. 
 
In evaluating the reliability of this analysis, the limited size of the control cohort must be 
considered. Herein, this fact is displayed as a large SD of the age-group results, caused by 
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interindividual variation. The area under the normal variation curve below +2.5 SD covers 
99.4% of all data values. Assuming that the control cohort follows the normal distribution, 
and the threshold limit of anomaly is set at +2.5 SD from the average, then theoretically 1 
in 167 unselected patients without an anomaly would exceed the upper limit and thus 
receive a false positive diagnosis. A lower threshold limit was used to ensure the 
sensitivity of the screening, whereas higher limit yields better specificity of the diagnosis. 
In an adult population, the emphasis may be on limitation of false positive findings, 
whereas in children it is beneficial to identify all subjects that need closer follow-up. 
6.2. Radiographic evaluation of cranial base dimensions 
 
In healthy children, the more caudal relative position of the odontoid process (as measured 
from the tip of the body of the dens) detected below the age of 9 years, is likely to be due 
to the tip not being yet fully mineralized and fused to the body of the dens, which usually 
occurs by 12 years (III) (Menezes 2008b). 
 
In assessing basilar impression, the use of Chamberlain’s line as a reference has been 
criticised because of the difficulty in locating the posterior reference point; the opisthion 
(McGregor 1948). In addition, as pointed out by Kovero and collegues (2006), the hard 
palate in growing OI patients is likely to be an unstable reference structure. Our study 
confirms the recommendation of Kovero et al. (1996) of the suitability of the D-M 
measure as a reference line in growing individuals. No statistically significant age-related 
change in the measure was observed, as is expected from the early stabilisation of the 
nasion-sella level during growth. Contrary to the findings of Bull and colleagues (1955), 
age was shown to be a relevant factor in assessing basilar pathology, whereas gender is 
not. This view is shared by Cronin and co-workers (2007 and 2009), who demonstrated 
the lack of statistically significant differences, in cranial base measures, between the sexes 
in healthy adult population. 
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Diagnosis of basilar pathology is reliably done on an MR or CT scan. Lateral skull 
radiographs have been recommended as a screening method at individually adjusted 
intervals. A baseline cephalometric study has been recommended for all patients with OI 
before school age. (OI-consensus conference, 17-18 November 1999, Sørmarka, Norway) 
6.3. Natural course of basilar pathology 
 
The findings of this study are in agreement with earlier observations in that the anterior 
cranial base angle steepens with growth (Kerr and Hirst 1987, George 2005). Similar to 
the work by George (2005), a statistically significant decrease occurred only before the 
age of 3 years in healthy subjects. In the cohort of Kerr and Hirst (1987) the anterior 
cranial base angle was on average 142° at birth and reduced to 130° by 5 years of age. 
Here, the angle was 137° on average at birth and decreased to 130° by 5 years in healthy 
subjects. A growth-related steepening was seen, similar to that of healthy individuals, in 
OI patients. In growing OI population (aged 0-18 years) the anterior cranial base angle has 
been reported to have a range between 160-175° (Janus et al. 2003); however in this study 
cohort of the same age, the angle was 144° on average, and ranged between 118-197° 
(IV). In study III, the mean angle was 134° with a range of 94-170° for the whole cohort. 
McGregor (1948) considered an angle above 148° to be highly suggestive of platybasia in 
young adults, but the threshold limit was lower in all age groups in this study based on the 
values of healthy controls. 
 
In the adult OI population, the prevalence figures of basilar pathology differ somewhat 
from those of growing patients. Basilar invagination has been documented in 22.2% of 
adults with OI (types I, III, and IV studied) (Kovero et al. 2006), however the 
corresponding figure for growing patients in study III was 4% and in study IV was 13%, 
when the same threshold value of +3 SD from the average of healthy age-matched 
controls was applied for both cohorts. In adult OI patients, the prevalence of basilar 
impression has been reported to be 17% (Kovero et al. 2006), whereas here, in growing 
patients, the prevalence was 6% (study III) and 9.5% (study IV) with the +3 SD threshold 
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limit. Platybasia was present in 11.1% of adults with OI. Platybasia was seen in 16% of 
patients in study III and 25.7% in study IV with the +3 SD threshold limit. The difference 
in the prevalence of cranial base anomaly between studies III and IV might be partly due 
to different examiners conducting the analyses. Moreover, in study III, the most recent 
radiograph was examined, whereas in study IV the first available one was selected. The 
percentage of patients with mild OI type I was similar in both study cohorts, however. 
 
Menezes (2008e) postulated that adolescence is a critical stage for development of 
craniocervical junction pathology. In most disorders, where craniocervical junction 
anomaly is a possible complication, it emerges typically during the growth spurt, between 
11 and 15 years of age. In patients with OI, the occurrence of cranial base anomalies has 
been previously observed at all ages from two years onwards (Sillence et al. 1993 as cited 
in Primorac), as was confirmed in this study. Likewise, no association has been found 
between age and development of scoliosis in growing OI patients (Engelbert et al. 1998). 
 
In OI, the thinner cortices cause bone to bow and break easily. This bending of bone 
and/or microfractures, and/or possibly adaptive changes in the cartilaginous 
synchondroses, could explain the observed occurence of platybasia from birth. The 
spheno-occipital synchondrosis appeared exceptionally wide in our material, age 
considered, in several patients. This finding remains to be analysed in a forthcoming 
study. Repeated microfractures combined with bending of bone and ligament laxity would 
explain the reason for craniocervical pathology becoming evident after a child attains an 
upright posture. A delay in adoption of the upright position has been documented in 
children with OI. The delay is most evident in the severe forms of the disorder. The mean 
age of sitting by OI type is 11 months for type I, 19 months for type III, and 10 months for 
type IV. Similarly standing has been reported to occur on average by 11 months in type I, 
40 months in type III, and 16 months in type IV. (Sutton et al. 2011) 
 
Chamberlain (1939) suspected a progressive worsening of the craniocervical pathology or 
a delay in the appearance of symptoms to take place. Progressivity of anomalies was also 
suspected by Charnas and Marini (1993) and Sillence (1994). We found no statistical 
evidence of progression nor an age related factor in incidence of abnormality. The only 
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factor associated with occurrence of cranial base anomaly was the clinical severity of OI. 
Our findings were similar to those of Janus and co-workers (2003), who followed seven 
patients for 2-6 years with MR scans after an abnormal finding on lateral skull radiograph. 
They observed no signs of progression in six patients and progression in one. In the same 
seven patients, anterior cranial base angle increased in follow-up. Despite the anatomical 
abnormality, neurologic symptoms were not detected. Janus recommends obtaining an 
image of the cranium when symptoms are present, and suggests that children that have 
undergone occipitocervical stabilization or decompression surgery should be monitored 
carefully because growth of the posterior fossa and clivus continue past adolescence and 
might further alter the relations of the structures of craniocervical junction. 
 
Platybasia did not improve spontaneously in the longitudinal follow-up (III, IV). In 
contrast, basilar invagination and impression interestingly passed off in some patients. The 
improvement in McRae measure is likely to occur as a result of growing number of 
microfractures lowering the posterior fossa leading to upward infolding of the occipital 
condyles and posterior edge of foramen magnum (Sillence 1994), thus raising McRae’s 
line. The reason for the observed change into a negative value of the D-M measure 
remains unknown and this development is somewhat contradictory to the previously 
observed progressive change in skull shape towards overhanging of the occiput (Charnas 
and Marini 1993). 
 
Severe growth failure was found here to suggest the presence of a craniocervical junction 
anomaly in OI patients. On the other hand, shortened distance between the skull base and 
shoulders, as caused by craniocervical abnormality, can in turn partly result in shortened 
overall height. Careful follow-up of subjects with a low height Z-score, combined with 
clinically short neck, is thus warranted. 
 
In patients with OI, the mean head circumference is within normal limits but has been 
reported to increase relative to body height (Lund et al. 1999). Charnas and Marini (1993) 
found that an increase in head circumference followed the normal curve for most patients. 
In 13 out of 46 patients, however, macrocephaly progressively advanced to reach an 
average head circumference Z-score of 2.1 ± 1.3. In 5 out of 76 patients, basilar 
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impression was discovered without related symptoms. Charnas and Marini (1993) 
documented basilar impression in all patients with large head circumference. In contrast, 
Engelbert and co-workers (1998) found no significant relationship between the head 
circumference Z-score and the presence of basilar impression in 47 paediatric patients. 
They also found basilar impression to be more commonly associated with kyphosis than 
with scoliosis. Children with generalized joint hypermobility had a lower incidence of 
scoliosis. Those children were also less prone to develop basilar impression. Engelbert 
speculated that microfractures of the vertebrae are the cause of spinal complications in 
patients with OI. Contrary to this view, laxity of spinal ligaments, thus vertebral 
instability, has been proposed to underlie progressive spinal curvature (Benson and 
Newman 1981, Hanscom et al. 1992). Scoliosis is a rare finding in patients with OI under 
the age of five, and is more common in the more severe forms of OI (Benson and 
Newman 1981). In evaluating scoliosis, change in sitting height is compared with angular 
spinal changes (Dimeglio 2001). Scoliosis has been previously noted to naturally progress 
at an individual rate in growing patients with OI without treatment (Hanscom et al. 1992). 
Hanscom and co-workers (1992) observed a partial loss of straightening, achieved in an 
arthrodesis operation, during a follow-up period. Of the 17 out of 56 patients with 
scoliosis, 11 also had craniocervical pathology, but association between these two could 
not be statistically shown (Hanscom et al. 1992). 
 
Sillence (1994) recommends radiological screening of the cranial base in type I OI, at 3 to 
5 year intervals, until skeletal maturity, after which no follow-up is needed if the findings 
are normal. In types III and IV, he suggests screening at 2 to 3 year intervals. Initial 
screening at the age of 5 years is recommended in severe forms. If no pathology is 
detected, a follow-up based on clinical symptoms is enough. Sillence also recommends 
delaying the upright position of a child. Notably his study reports a smaller frequency of 
neurologic symptoms than pathologic findings in radiographs or CT images. Based on our 
findings, we confirm that radiological analysis of cranial base dimensions with 
measurements described should be carried out for all patients before school age. In 
severely affected children, a radiograph or MR image is often taken already in infancy to 
facilitate diagnosis and classification of OI, and should be subjected to analysis of 
craniocervical junction. In case of normal findings from the image(s) taken before school 
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age, further imaging is unnecessary in symptomless patients to retain the patient radiation 
dose at a minimum. In the cases of abnormal findings in a radiograph and MR image, an 
individually adjusted plan for follow-up and treatment is warranted (Figure 11). 
Figure 11 The outline of suggested clinical management with imaging 
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7. Conclusions 
The radiographic analysis methods used here are applicable for screening of basilar 
pathology. By analysing lateral radiographs of the midsagittal plane, the variation in 
anatomic landmark location was found to lead to differences in numeric evaluation of the 
anatomic relationships of the cranial base and craniocervical junction. These differences 
were, however, shown to have little clinical significance. (I) 
 
Of the commonly used measurements in evaluating basilar pathology, the McGregor 
measure was the least sensitive to errors in landmark identification. The McGregor 
measure is, however, significantly age dependent and thus not as suited to paediatric 
subjects as the least age sensitive measure, D-M distance (II). In patients with OI, D-M 
distance was confirmed to be a more sensitive indicator of basilar impression than the 
Chamberlain or McGregor measures (III). The novel D-M angle measure is unaffected by 
radiographic magnification and has high correlation with D-M distance, which further 
increases the superiority of D-M angle in evaluating basilar impression (IV). 
 
The vertical dimensions of the craniocervical junction and the flexion of the anterior skull 
base change in healthy individuals during growth. Consequently the normal values for the 
cranial base measures are age dependent. Notable individual variation in measures during 
growth may appear. Our findings indicate that in 5–6-year-old children, the cranial base 
measurements are significantly different from older age groups, and studies on patients 
younger than 9 should be provided with age-appropriate controls. (II) We provide 
reference values for growing individuals (II, IV). 
 
A notable deviation from the normal values is suggestive of pathological development and 
indicates a need for further examination. Cranial base anomalies were present in 22% of 
OI patients in the cohort of study III and 32% of the patient cohort in study IV, as assessed 
by the limit of pathology set at 3 SD above the values of healthy age-matched controls. 
Platybasia was the most frequent finding. (III, IV) Detection of platybasia from birth 
suggests intrauterine development, whereas basilar impression and invagination were 
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detected from the age of 2 years onwards (IV). Platybasia had a tendency to persist, 
whereas the natural course of basilar invagination and impression showed more variation. 
 
Severely affected OI patients with very short stature are at the highest risk of developing 
cranial base anomalies (III, IV). We did not find evidence for progression of the pathology 
or for a protective effect of bisphosphonate treatment (III, IV). These findings favour the 
hypothesis that other than bony structures –skull base cartilage and craniocervical junction 
ligaments– might be involved in the development of these pathological conditions, in 
addition to changes in bones. 
 
Early recognition of cranial base anomalies, and implementation of treatment is important 
before irreversible neurological defects arise. Based on the findings of this thesis, 
radiological analysis of cranial base dimensions with measurements described should be 
carried out for all patients before school age. In the case of normal findings from the initial 
image(s), further imaging is unnecessary in symptomless patients. Where abnormal 
findings in a radiograph or MR image are evident, an individually adjusted plan for 
follow-up and treatment is warranted. 
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8. Clinical recommendations and future considerations 
The following clinical recommendations are proposed based on this study: 
 
o Basilar pathology should be suspected in patients with OI and a low height Z-score. 
o When assessing basilar anomalies, age-matched controls should be used with patients 
under 9 years of age. 
o Basilar invagination is feasibly diagnosed with the McRae measure, basilar impression 
with D-M angle, and platybasia by measuring the anterior cranial base angle. 
o The outline of suggested clinical management with imaging is presented (Figure 11). 
 
With bisphosphonates becoming the treatment of choice from a young age, the natural 
course of development of cranial base anomalies in patients with OI may be lost, assuming 
that changes in bony structures bear a considerable responsibility for the development of 
the pathology. Future prospects certainly include studies on the effects of bisphosphonates 
on cranial base anomalies. Bisphosphonates are unlikely to reduce the prevalence of early 
onset platybasia, and do not directly affect the ligaments constituting an essential part of 
the junction. The increased stiffness of bone caused by bisphosphonates might even 
increase the prevalence of platybasia due to microfractures as the brain grows in volume. 
The favourable effects of bisphosphonate treatment on infants with severe forms of OI 
might lead to an adoption of an upright position earlier and as a result the weight of the 
cranium compressing the cervical spine earlier in growth. 
 
The natural course of cranial base anomalies in other connective tissue disorders besides 
OI should also be examined. This study can serve as a benchmark for future studies. 
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